Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inozyme Pharma, Inc. | Director | Stock Option (right to buy) | 28K | Jun 18, 2024 | Direct | ||
IVERIC bio, Inc. | Director | Common Stock | 0 | $39.45 | Jul 11, 2023 | Direct | |
IVERIC bio, Inc. | Director | Restricted Stock Units | 0 | Jul 11, 2023 | Direct | ||
IVERIC bio, Inc. | Director | Stock Option (Right to Buy) | 0 | $10.03 | Jul 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INZY | Inozyme Pharma, Inc. | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
ISEE | IVERIC bio, Inc. | Jul 11, 2023 | 8 | $0 | 4 | Jul 13, 2023 | Director |
INZY | Inozyme Pharma, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
ISEE | IVERIC bio, Inc. | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
ISEE | IVERIC bio, Inc. | May 11, 2023 | 2 | $0 | 4 | May 15, 2023 | Director |
INZY | Inozyme Pharma, Inc. | May 1, 2023 | 1 | $0 | 4 | May 3, 2023 | Director |
INZY | Inozyme Pharma, Inc. | Mar 31, 2023 | 1 | $10.6K | 4 | Apr 4, 2023 | Director |
INZY | Inozyme Pharma, Inc. | Sep 30, 2022 | 1 | $7.56K | 4 | Oct 4, 2022 | Chief Executive Officer, Director |
ISEE | IVERIC bio, Inc. | May 11, 2022 | 4 | $0 | 4 | May 13, 2022 | Director |
INZY | Inozyme Pharma, Inc. | Apr 19, 2022 | 1 | $250K | 4 | Apr 20, 2022 | Chief Executive Officer, Director |
INZY | Inozyme Pharma, Inc. | Feb 24, 2022 | 1 | $0 | 4 | Feb 28, 2022 | Chief Executive Officer, Director |
INZY | Inozyme Pharma, Inc. | Jun 24, 2021 | 3 | $65.4K | 4 | Jun 25, 2021 | Chief Executive Officer, Director |
ISEE | IVERIC bio, Inc. | May 19, 2021 | 2 | $0 | 4 | May 20, 2021 | Director |